Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl
- Status
- WITHDRAWN
- Phase
- PHASE2
18F-DOPA II - PET Imaging Optimization
- Status
- RECRUITING
- Phase
- PHASE3
Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs
- Status
- COMPLETED
- Phase
- N/A
Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Telotristat With Lutathera in Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Impact of Peptides and Chelators on Somatostatin Receptor Antagonists
- Status
- UNKNOWN
- Phase
- PHASE2
Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s
- Status
- TERMINATED
- Phase
- N/A
Nutrition in Gastrointestinal Tumors
- Status
- COMPLETED
- Phase
- N/A
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
- Status
- RECRUITING
- Phase
- N/A
Registry on NEN Patients and COVID-19
- Status
- UNKNOWN
- Phase
- N/A